Signals, Powered By EquityPandit
Syngene International which is a research arm of Biocon, has appointed Jonathan Hunt as its CEO-designate.
Syngene International said in a regulatory filing that Jonathan Hunt will be taking charge after the retirement of current CEO Peter Bains in March.
It further added that Bains who has worked as a director since 2010, was appointed as the CEO in February and will continue as a member of the board post.
Kiran Mazumdar-Shaw, Syngene International MD said that “Hunt has a rich experience in the global bio-pharmaceutical industry and a proven track record of leading transformational change and delivering growth.”
“We are sure under his leadership Syngene will continue to strengthen its position in the global contract research and manufacturing services market,” she said further.
